Skip to main content

Table 3 Multivariate logistic regression analysis of the influence of five biochemical markers on patients with HF

From: Evaluating the link between DIO3-FA27 promoter methylation, biochemical indices, and heart failure progression

Variables

Case

Group

β-value

SE

P-value

OR

95% CI

Coagulation indicators

APTT

10

Q1

Reference

10

Q2

− 1.17

1.66

0.48

0.31

0.01–8.05

10

Q3

3.30

1.64

0.04

27.00

1.08–674.12

10

Q4

5.58

2.17

0.01

264.04

3.76–18,548.4

FDP

10

Q1

Reference

10

Q2

− 6.65

2.15

0.00

0.00

0.00–0.09

10

Q3

− 3.95

1.72

0.02

0.02

0.00–0.57

10

Q4

− 3.49

1.72

0.04

0.03

0.00–0.90

Renal indicators

Urea

10

Q1

Reference

10

Q2

0.41

0.90

0.65

1.50

0.26–8.82

10

Q3

− 2.20

1.23

0.07

0.11

0.01–1.24

10

Q4

1.39

1.01

0.17

4.00

0.55–29.10

Blood routine indicators

MCV

10

Q1

Reference

10

Q2

− 2.20

1.23

0.07

0.11

0.01–1.24

10

Q3

− 2.60

1.24

0.04

0.07

0.00–0.84

10

Q4

− 3.58

1.32

0.00

0.03

0.00–0.37

Lipid indicators

HDL

10

Q1

Reference

10

Q2

1.35

1.26

0.28

3.86

0.33–45.57

10

Q3

3.05

1.26

0.02

21.00

1.78–248.10

10

Q4

4.40

1.49

0.00

81.00

4.36–1504.46

Liver indicators

ALP

10

Q1

Reference

10

Q2

− 0.54

1.05

0.61

0.58

0.08–4.56

10

Q3

− 1.80

1.02

0.08

0.17

0.02–1.23

10

Q4

− 3.39

1.32

0.08

0.03

0.00–0.37